Price alert —
Sign in to get a one-time email the moment DVA crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · DVA
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3.4B | $0.2B | $0.5B | $0.2B | 5.8% | 13.9% |
| 2025-12-31 | $3.6B | $0.2B | $0.6B | $0.4B | 6.5% | 15.2% |
| 2025-09-30 | $3.4B | $0.2B | $0.5B | $0.7B | 4.4% | 14.5% |
| 2025-06-30 | $3.4B | $0.2B | $0.5B | $0.2B | 5.9% | 15.7% |
| 2025-03-31 | $3.2B | $0.2B | $0.4B | $0.0B | 5.1% | 13.4% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare DVA vs peers
Line DVA up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with DVA
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-05 | 2.87 | 2.33 | +23.2% | +23.5% |
| 2026-02-02 | 3.40 | 3.19 | +6.5% | +21.2% |
| 2025-10-29 | 2.51 | 3.17 | -20.9% | -6.2% |
| 2025-08-05 | 2.95 | 2.75 | +7.3% | -9.0% |
| 2025-05-12 | 2.00 | 2.02 | -0.9% | -0.3% |
| 2025-02-13 | 2.24 | 2.13 | +5.4% | -11.1% |
| 2024-10-29 | 2.59 | 2.72 | -4.9% | -10.8% |
| 2024-08-06 | 2.59 | 2.63 | -1.4% | -2.2% |
| 2024-05-02 | 2.38 | 1.92 | +23.7% | -5.5% |
| 2024-02-13 | 1.87 | 1.66 | +12.8% | +8.6% |
| 2023-11-07 | 2.85 | 2.04 | +39.9% | +5.9% |
| 2023-08-03 | 2.08 | 1.74 | +19.8% | +7.1% |
| 2023-05-08 | 1.58 | 1.22 | +29.8% | +12.9% |
| 2023-02-22 | 1.11 | 0.98 | +12.8% | -2.9% |
| 2022-10-28 | 1.45 | 1.76 | -17.6% | +3.5% |
| 2022-08-01 | 2.30 | 2.08 | +10.4% | +1.9% |
| 2022-05-05 | 1.61 | 1.87 | -13.8% | -3.7% |
| 2022-02-10 | 2.02 | 1.80 | +12.3% | +0.1% |
| 2021-10-28 | 2.36 | 2.26 | +4.6% | -9.5% |
| 2021-08-03 | 2.64 | 2.17 | +21.5% | +8.6% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| DVA ★ | $15B | 22.8 | 13.8 | 1.1 | 10.6 | -20.8 | 32.5% | 6.0% | 43.5% | 6.57% |
| LLY | — | 41.8 | 26.3 | — | 30.1 | — | 82.8% | 55.5% | 169.9% | — |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | — | 36.0 | 13.2 | — | 12.1 | 6.9 | 76.7% | 4.9% | — | — |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | — | 19.1 | 8.8 | — | 7.6 | — | 74.8% | 5.4% | -10.1% | — |
| TMO | — | 29.2 | 19.5 | — | 21.1 | — | 40.9% | 6.2% | 11.3% | — |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 68.87%
| Holder | Shares | % out |
|---|---|---|
| Berkshire Hathaway, Inc | 30,100,585 | 46.89% |
| Blackrock Inc. | 2,766,751 | 4.31% |
| Vanguard Capital Management LLC | 2,180,225 | 3.40% |
| Morgan Stanley | 1,666,038 | 2.60% |
| Vanguard Portfolio Management LLC | 1,479,600 | 2.30% |
| Invesco Ltd. | 1,467,881 | 2.29% |
| State Street Corporation | 1,351,737 | 2.11% |
| Dimensional Fund Advisors LP | 1,145,436 | 1.78% |
| Arrowstreet Capital, Limited Partner | 1,110,151 | 1.73% |
| Geode Capital Management, LLC | 939,781 | 1.46% |
Insider activity · 90d
8 buys / 5 sells · ratio 1.6 · Finnhub
- Rodriguez Javier SELL 840,408 @ $209.28
- Waters Kathleen Alyce SELL 109,194 @ $209.17
- Waters Kathleen Alyce SELL 115,649 @ $207.84
- Rodriguez Javier SELL 879,815 @ $209.50
- YALE PHYLLIS R G 9,525
- Pullin Dennis W BUY 2,671
- Moore Gregory J. BUY 7,813
- HEARTY JAMES O SELL 22,389 @ $193.98
- Hollar Jason M. BUY 6,605
- Arway Pamela M BUY 26,945
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
No CIK found for DVA.
About DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Options picks · DVA
ITM + OTM ideas from the latest scanLoading…
Congress trades · DVA
STOCK Act disclosuresLoading…
SEC filings & insiders · DVA
EDGAR · liveLoading…
Holders · DVA
Institutions & insider activityLoading…